Consumer Defensive
Live Price
Offline$141.18
+1.60% today
1Y Change
-9.06%
Window
Jun 23, 2025 → Jun 12, 2026
Coverage: 245 bars · Jun 23, 2025 → Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Constellation Brands, Inc. (STZ) is a Consumer Defensive stock with a market cap of $26.31B and listed on NYSE. The stock last traded around $141.18 and down 9.1% across the available one-year price window (Jun 23, 2025 → Jun 12, 2026). Baseline metrics include revenue growth of -10.5%, EPS growth of +2237.8%, a dividend yield of 2.7%. What stands out right now is revenue -10.5%, EPS +2237.8%, free cash flow -7.4% with operating margin 31.3% and ROIC 10.5%. The dividend matters to the case here, with a current yield around 2.7%. Valuation is more restrained than many high-expectation growth names at P/E 15.7 and price/sales 2.9. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines STZ price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
STZ
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
STZ Max Drawdown
-27.51%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for STZ and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$8.6B
-2.4% YoY
FY Net Income
$2.0B
+5045.5% YoY
Free Cash Flow
$1.9B
+15.7% YoY
Revenue Growth
-10.5%
EPS Growth
+2237.8%
Gross Margin
51.7%
Net Margin
18.5%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 10.2B | 10.0B | 9.5B | 8.8B | 8.6B |
| Gross Profit | 5.2B | 4.9B | 4.8B | 4.6B | 4.5B |
| Operating Income | 3.6B | 3.1B | 3.0B | 2.9B | 2.9B |
| EBITDA | 783M | 3.1B | 1.2B | 1.0B | 3.2B |
| Net Income | -81M | 1.7B | -71M | -40M | 2.0B |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 68M | 152M | 134M | 199M | 461M |
| Total Assets | 21.7B | 25.7B | 24.7B | 25.9B | 27.1B |
| Total Liabilities | 14.5B | 15.6B | 15.9B | 13.8B | 13.2B |
| Shareholder Equity | 6.9B | 9.7B | 8.4B | 11.7B | 13.6B |
| Total Debt | 12.1B | 12.6B | 13.0B | 11.0B | 11.0B |
| Net Debt | 12.0B | 12.4B | 12.8B | 10.8B | 10.5B |
Cash flow positioning
Latest Full Year
Operating Cash Flow
2.8B
+3.7% YoY
Capital Expenditures
865M
+15.8% YoY
Free Cash Flow
1.9B
+15.7% YoY
Key ratios
Gross Margin
51.7%
Operating Margin
31.3%
Net Margin
18.5%
ROE
22.1%
Debt / Equity
1.39x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.